Lithium Hydroxide → HCID 86657001, compound
Reaction equation
C[O:2][C:3](=[O:33])[C@@H:4]([NH:6][C:7]([C:9]1[CH:32]=[CH:31][C:12]2[N:13]([CH3:30])[C:14]([NH:16][C:17]3[S:18][C:19]4[CH:25]=[C:24]([C:26]([F:29])([F:28])[F:27])[CH:23]=[CH:22][C:20]=4[N:21]=3)=[N:15][C:11]=2[CH:10]=1)=[O:8])[CH3:5].[OH-].[Li+]>>[CH3:30][N:13]1[C:12]2[CH:31]=[CH:32][C:9]([C:7]([NH:6][C@@H:4]([CH3:5])[C:3]([OH:33])=[O:2])=[O:8])=[CH:10][C:11]=2[N:15]=[C:14]1[NH:16][C:17]1[S:18][C:19]2[CH:25]=[C:24]([C:26]([F:29])([F:28])[F:27])[CH:23]=[CH:22][C:20]=2[N:21]=1Participants
3
Procedure
(S)-2-{[1-Methyl-2-(6-trifluoromethyl-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carbonyl]-amino}-propionic acid (743 mg) was prepared by following General Procedure E starting from (S)-2-{[1-methyl-2-(6-trifluoromethyl-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carbonyl]-amino}-propionic acid methyl ester (850 mg) and lithium hydroxide (299 mg).
Sources & evidence
- ORD record
- ord-e133b2a39087459089b62b7251630734
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08759535B2
Reaction notes
Loading…